Imatinib induces dose-dependent in K562 cells.

Imatinib induces dose-dependent in K562 cells.

<p>Cells were treated with escalating doses imatinib for 24 and 48 hr. Cell viability assessed using MTT assay. (Plot: Mean with SD, n = 3, *p<0.05, **P < 0.01, ***P <0.001).</p>

Saved in:

Bibliographic Details
Main Author:	Niloofar Jaafari (20565217) (author)
Other Authors:	Amir Asri Kojabad (19964757) (author), Rima Manafi Shabestari (20565220) (author), Majid Safa (9505895) (author)
Published:	2025
Subjects:	Biochemistry Medicine Cell Biology Pharmacology Biotechnology Cancer Hematology Infectious Diseases Virology Computational Biology Chemical Sciences not elsewhere classified small sample volumes requiring fewer reagents measured using annexin manipulate small volumes chronic myeloid leukemia long screening times reduce assay costs chip &# 8217 xlink "> herein xlink "> compared drug screening time using microfluidic chips microfluidic device compared employ microfluidic chips cell isolation technologies traditional drug screening throughput screening assays k562 cells treated xlink "> drug screening cells treated microfluidic chip traditional approaches drug discovery based assays k562 cells novel microfluidic innovative microfluidic well plates treatment optimization study aimed present study pi staining maintaining biocompatibility increases sensitivity holistic understanding high costs challenges associated cell viability cell analysis based droplets 48 hours
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_freocckpgbjm6hmukaukk9q75k